4D Pharma

4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved therapeutic effect. Its MicroRx methodology offers a pipeline of approximately 10 therapeutic programs covering autoimmune diseases, central nervous system (CNS) disorders and cancer. The Company uses MicroRx to develop its programs into the clinic and has approximately two programs in patient trials. The Company focuses on immune conditions, such as pediatric Crohn's, pediatric colitis and irritable bowel syndrome.
Type
Public
HQ
Leeds, GB
Size (employees)
24 (est)
4D Pharma is headquartered in Leeds, GB

4D Pharma Office Locations

4D Pharma has an office in Leeds
Leeds, GB (HQ)
9 Bond St

4D Pharma Data and Metrics

4D Pharma Financial Metrics

£, GBP

Net income (FY, 2015)

(7.7 m)

Market capitalization (21-Jun-2017)

167 m

Closing share price (21-Jun-2017)

2.6

Cash (31-Dec-2015)

85.4 m
4D Pharma's current market capitalization is £167 m.
£, GBPFY, 2014FY, 2015

Pre tax profit

(2.4 m)(10.1 m)

Net Income

(2.4 m)(7.7 m)
£, GBPFY, 2014FY, 2015

Cash

31.8 m85.4 m

Current Assets

32.5 m90.1 m

PP&E

695 k1.1 m

Goodwill

6.3 m6.2 m

Total Assets

39.5 m97.4 m

Accounts Payable

1.4 m2.9 m

Current Liabilities

1.8 m4.3 m

Retained Earnings

(2 m)(7.5 m)

Total Equity

37.3 m92.7 m

Financial Leverage

1.1 x1.1 x
£, GBPFY, 2014FY, 2015

Cash From Operating Activities

(3.8 m)(9.1 m)

Cash From Financing Activities

36.7 m63.8 m

Income Taxes Paid

2.3 m
Y, 2015

Financial Leverage

1.1 x

4D Pharma Market Value History

4D Pharma Company Life and Culture

You may also be interested in